I would like to reply to Angelica Oung's article ("Cancer drug shows greater efficacy in Taiwanese patients," Nov. 13, page 2) by noting that there was a recent study in the US describing correlations between cell culture assay results (cell death in response to Iressa exposure) and the survival of patients with non-small-cell lung cancer who had received extensive prior chemotherapy.
These correlations were based on the actual assay results given to the doctors who ordered the laboratory tests. There were striking correlations between the results of the tests and patient survival.
The study utilized a new test called EGFRx, which accurately predicted the survival of patients treated with many emerging drugs. This is important because the EGFRx test could help to solve the growing problem of knowing which patients should receive costly, new treatments that can have harmful side-effects and which treatments will work for some -- but not all -- cancer patients.
Another benefit of the EGFRx test is that it can discriminate between the effects of different drugs and identify situations in which it would be advantageous to provide drug combinations.
The new test relies upon "whole cell profiling," in which living tumor cells are removed from an individual cancer patient and exposed in the laboratory to the new drugs. A variety of metabolic and apoptotic measurements are then used to determine if a specific drug could be successful in killing the patient's cancer cells.
After being exposed to Iressa, cancer cells undergo apoptosis and die. This has been found at the whole-cell level in the cell culture assays and has been reported to be strikingly correlated with patient survival.
The whole cell profiling method differs from other tests in that it assesses the activity of a drug upon the combined effect of all cellular processes, using metabolic and morphologic endpoints.
Other tests, such as those that identify DNA or RNA sequences or individual protein expression, often examine only one component of a much larger, interactive process.
The effects of drugs targeting EGF (Iressa, Tarceva, Erbitux) are poorly predicted by measuring the ostensible target (EGFR), but can be predicted more accurately by measuring the effect of the drugs on the function of live cells.
This is an area of cancer research that had been abandoned by most of the cancer research establishment except for a small band of cell biologists.
If Iressa works for some people, then obviously there must be others out there who would also benefit. This is a great argument for cell culture assay testing for tumors.
Gregory Pawelski
Pennsylvania
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
Can US dialogue and cooperation with the communist dictatorship in Beijing help avert a Taiwan Strait crisis? Or is US President Joe Biden playing into Chinese President Xi Jinping’s (習近平) hands? With America preoccupied with the wars in Europe and the Middle East, Biden is seeking better relations with Xi’s regime. The goal is to responsibly manage US-China competition and prevent unintended conflict, thereby hoping to create greater space for the two countries to work together in areas where their interests align. The existing wars have already stretched US military resources thin, and the last thing Biden wants is yet another war.
As Maldivian President Mohamed Muizzu’s party won by a landslide in Sunday’s parliamentary election, it is a good time to take another look at recent developments in the Maldivian foreign policy. While Muizzu has been promoting his “Maldives First” policy, the agenda seems to have lost sight of a number of factors. Contemporary Maldivian policy serves as a stark illustration of how a blend of missteps in public posturing, populist agendas and inattentive leadership can lead to diplomatic setbacks and damage a country’s long-term foreign policy priorities. Over the past few months, Maldivian foreign policy has entangled itself in playing
A group of Chinese Nationalist Party (KMT) lawmakers led by the party’s legislative caucus whip Fu Kun-chi (?) are to visit Beijing for four days this week, but some have questioned the timing and purpose of the visit, which demonstrates the KMT caucus’ increasing arrogance. Fu on Wednesday last week confirmed that following an invitation by Beijing, he would lead a group of lawmakers to China from Thursday to Sunday to discuss tourism and agricultural exports, but he refused to say whether they would meet with Chinese officials. That the visit is taking place during the legislative session and in the aftermath